Virtual ISPOR 2021 Prerelease Session on HTAs in Clinical Trial Design

ISPOR will take place virtually from May 17^th to 20^th. Prerelease sessions will be available beginning on April 21^st and available until June 30^th, along with recordings from the conference. In a prerelease session moderated by Dr. Donna Messner, President and CEO of the Center for Medical Technology Policy, panelists will discuss how an ICER-like HTA (health technology assessment) would impact drug development.

“Panelists will explore the potential value of payer and health technology assessor (HTA) participation in consensus-based core outcome set (COS) development for drug clinical trials, discuss hurdles to their participation and debate the potential benefits (or drawbacks) of COS to coverage and payment decision-making.” Read more here.

(Source: ISPOR, 2021)